Expression of costimulatory molecules in low-grade mucosa-associated lymphoid tissue-type lymphomas in vivo

American Journal of Pathology

Volumn 155, Issue 6, 1999, Pages 2019-2027

  Knörr, Constanze ^a   Amrehn, Christa ^a   Seeberger, Harald ^a   Rosenwald, Andreas ^a   Stilgenbauer, Stephan ^b   Ott, German ^a   Müller Hermelink, Hans Konrad ^a   Greiner, Axel ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER GRADING; CELL PROLIFERATION; CELL SURVIVAL; CHROMOSOME ABERRATION; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN TISSUE; IMMUNOCOMPETENCE; IN VIVO STUDY; LIGAND BINDING; LYMPHOID TISSUE; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0344146433     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65521-6     Document Type: Article

References (54)

1. Greiner A, Müller Hermelink HK: Recent advances in gastric extranodal B-cell lymphoma. Curr Diagn Pathol 1996, 3:91-98
2. Greiner A, Knörr C, Qin Y, Sebald W, Schimpl A, Banchereau J, Müller Hermelink HK. Low-grade B cell lymphomas ot mucosa-associated lymphoid tissue (MALT-type) require CD40-mediated signaling and Th2-type cytokines for in vitro growth and differentiation. Am J Pathol 1997, 150:1583-1593
3. Wotherspoon AC, Doglioni C, Diss TC, Pan L, Moschini A, de Boni M, Isaacson PG: Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet 1993, 342:575-577
4. Bayerdorffer E, Neubauer A, Rudolph B, Thiede C, Lehn N, Eidt S, Stolte M: Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection. MALT Lymphoma Study Group. Lancet 1995, 345:1591-1594
5. Hussell T, Isaacson PG, Crabtree JE, Spencer J: The response of cells from low-grade B-cell gastric lymphomas of mucosa-associated lymphoid tissue to Helicobacter pylori. Lancet 1993, 342:571-574
6. Greiner A, Knörr C, Qin Y, Schultz A, Marx A, Kroczek RA, Müller Hermelink HK: CD40 ligand and autoantigen are involved in the pathogenesis of low-grade B-cell lymphomas of mucosa-associated lymphoid tissue. Dev Immunol 1998, 6:187-195
7. Qin Y, Greiner A, Hallas C, Haedicke W, Müller Hermelink HK: Intraclonal offspring expansion of gastric low-grade MALT-type lymphoma: evidence for the role of antigen-driven high-affinity mutation in lymphomagenesis. Lab Invest 1997, 76:477-485
8. Hussell T, Isaacson PG, Crabtree JE, Dogan A, Spencer J: Immunoglobulin specificity of low grade B cell gastrointestinal lymphoma of mucosa-associated lymphoid tissue (MALT) type. Am J Pathol 1993, 142:285-292
9. Rathmell JC, Townsend SE, Xu JC, Flavell RA, Goodnow CC: Expansion or elimination of B cells in vivo: dual roles for CD40-and Fas (CD95)-ligands modulated by the B cell antigen receptor. Cell 1996, 87:319-329
10. Goodnow CC: Balancing immunity and tolerance: deleting and tuning lymphocyte repertoires. Proc Natl Acad Sci USA 1996, 93:2264-2271
11. Xu Amano J, Kiyono H, Jackson RJ, Staats HF, Fujihashi K, Burrows PD, Elson CO, Pillai S, McGhee JR: Helper T cell subsets for immunoglobulin A responses: oral immunization with tetanus toxoid and cholera toxin as adjuvant selectively induces Th2 cells in mucosa associated tissues. J Exp Med 1993, 178:1309-1320
12. Armitage RJ, Macduff BM, Spriggs MK, Fanslow WC: Human B cell proliferation and Ig secretion induced by recombinant CD40 ligand are modulated by soluble cytokines. J Immunol 1993, 150:3671-3680
13. Liu YJ, Arpin C: Germinal center development. Immunol Rev 1997, 156:111-126
14. Sher A, Coffman RL: Regulation of immunity to parasites by T cells and T cell-derived cytokines. Annu Rev Immunol 1992, 10:385-409
15. Pound JD, Gordon J: Maintenance of human germinal center B cells in vitro. Blood 1997, 89:919-928
16. Burdin N, van Kooten C, Galibert L, Abrams JS, Wijdenes J, Banchereau J, Rousset F: Endogenous IL-6 and IL-10 contribute to the differentiation of CD40-activated human B lymphocytes. J Immunol 1995, 154:2533-2544
17. De Vita S, Dolcetti R, Ferraccioli G, Pivetta B, De Re V, Gloghini A, D'Agosto A, Bartoli E, Carbone A, Boiocchi M: Local cytokine expression in the progression toward B cell malignancy in Sjogren's syndrome. J Rheumatol 1995, 22:1674-1680
18. Ott G, Katzenberger T, Greiner A, Kalla J, Rosenwald A, Heinrich U, Ott MM, Müller Hermelink HK: The t(11,18)(q21,q21) chromosome translocation is a frequent and specific aberration in low-grade but not high-grade malignant non-Hodgkin's lymphomas of the mucosa-associated lymphoid tissue (MALT-) type. Cancer Res 1997, 57: 3944-3948
19. Prabhu RM, Medeiros LJ, Kumar D, Drachenberg CI, Papadimitriou JC, Appelman HD, Johnson LB, Laurin J, Heyman M, Abruzzo LV: Primary hepatic low-grade B-cell lymphoma of mucosa-associated lymphoid tissue (MALT) associated with primary biliary cirrhosis. Mod Pathol 1998, 11:404-410
20. Greiner A, Seeberger H, Knörr C, Starostik P, Müller Hermelink HK: MALT-type B cell lymphomas escape the censoring FAS-mediated apoptosis. Blood 1998, 92:484
21. Harris NL, Jaffe ES, Stein H, Banks PM, Chan JK, Cleary ML, Delsol G. De Wolf Peeters C, Falini B, Gatter KC, Müller Hermelink HK, et al: A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994, 84 1361-1392
22. Greiner A, Marx A, Müller Hermelink HK, Schmausser B, Petzold K, Kruger H: Vascular autoantibodies in amyotrophic lateral sclerosis. Lancet 1992, 340:378-379
23. Greiner A, Schuster V, Bohm E, Kreth HW, Hermelink HK, Kreipe H: Regulary organized lymphoid tissue and CD40 ligand expression in a male fetus carrying the defective gene for X-linked lymphoproliferative disease (XLP). Histopathology 1997, 30:481-482
24. Friedland JS, Shattock RJ, Johnson JD, Remick DG, Holliman RE, Griffin GE: Differential cytokine gene expression and secretion after phagocytosis by a human monocytic cell line of Toxoplasma gondii compared with Mycobacterium tuberculosis. Clin Exp Immunol 1993, 91:282-286
25. Sharma V, Knobloch TJ, Benjamin D: Differential expression of cytokine genes in HIV-1 tat transfected T and B cell lines. Biochem Biophys Res Commun 1995, 208:704-713
26. Banchereau J, Rousset F: Growing human B lymphocytes in the CD40 system. Nature 1991, 353:678-679
27. Arpin C, Dechanet J, van Kooten C, Merville P, Grouard G, Briere F, Banchereau J, Liu YJ: Generation of memory B cells and plasma cells in vitro. Science 1995, 268:720-722
28. Arpin C, Banchereau J, Liu YJ: Memory B cells are biased towards terminal differentiation: a strategy that may prevent repertoire freezing J Exp Med 1997, 186:931-940
29. Greiner A, Marx A, Heesemann J, Leebmann J, Schmausser B, Müller Hermelink HK: Idiotype identity in a MALT-type lymphoma and B cells in Helicobacter pylori associated chronic gastritis. Lab Invest 1994, 70:572-578
30. Dallma MJ, Porter ACG: Semi-quantitative PCR of gene expression. PCR - A Practical Approach Edited by MJ Mcpherson, P Quirke, GR Taylor. Oxford University Press, London, 1991, pp 215-224
31. Grammer AC, Bergman MC, Miura Y, Fujita K, Davis LS, Lipsky PE: The CD40 ligand expressed by human B cells costimulates B cell responses. J Immunol 1995, 154:4996-5010
32. Fischbach W, Tacke W, Greiner A, Müller Hermelink HK: Regression of immunoproliferative small intestinal disease after eradication of Helicobacter pylori. Lancet 1997, 349:31-32
33. Hussell T, Isaacson PG, Crabtree JE, Spencer J: Helicobacter pylori-specific tumour-infiltrating T cells provide contact dependent help for the growth of malignant B cells in low-grade gastric lymphoma of mucosa-associated lymphoid tissue. J Pathol 1996, 178:122-127
34. Ashany D, Song X, Lacy E, Nikolic Zugic J, Friedman SM, Elkon KB: Th1 CD4+ lymphocytes delete activated macrophages through the Fas/APO-1 antigen pathway. Proc Natl Acad Sci USA 1995, 92: 11225-11229
35. Demanet C, Brissinck J, Leo O, Moser M, Thielemans K: Role of T-cell subsets in the bispecific antibody (anti-idiotype x anti-CD3) treatment of the BCL1 lymphoma. Cancer Res 1994, 54:2973-2978
36. Racila E, Scheuermann RH, Picker LJ, Yefenof E, Tucker T, Chang W, Marches R, Street NE, Vitetta ES, Uhr JW: Tumor dormancy and cell signaling. II. Antibody as an agonist in inducing dormancy of a B cell lymphoma in SCID mice. J Exp Med 1995, 181:1539-1550
37. Schattner EJ, Mascarenhas J, Bishop J, Yoo DH, Chadburn A, Crow MK, Friedman SM: CD4+ T-cell induction ot Fas-mediated apoptosis in Burkitt's lymphoma B cells. Blood 1996, 88:1375-1382
38. Friesen C, Herr I, Krammer PH, Debatin KM: involvement of the CD95 (APO-1/FAS) receptor/ligand system in drug-induced apoptosis in leukemia cells. Nature Med 1996, 2:574-577
39. Voorzanger-Rousselot N, Favrot M, Blay JY: Resistance to cytotoxic chemotherapy induced by CD40 ligand in lymphoma cells. Blood 1998, 92:3381-3387
40. Banchereau J, Bazan F, Blanchard D, Briere F, Galizzi JP, van Kooten C, Liu YJ, Rousset F, Saeland S: The CD40 antigen and its ligand. Annu Rev Immunol 1994, 12:881-922
41. Brugnoni D, Rossi G, Tucci A, Cattaneo R, Airo P: Study of CD40 ligand expression in B-cell chronic lymphocytic leukemia. Haematologica 1995, 80:440-442
42. Trentin L, Zambello R, Sancetta R, Facco M, Cerutti A, Perin A, Siviero M, Basso U, Bortolin M, Adami F, Agostini C, Semenzato G: B lymphocytes from patients with chronic lymphoproliferative disorders are equipped with different costimulatory molecules. Cancer Res 1997, 57:4940-4947
43. Greiner A, Marx A, Schmausser B, Müller Hermelink HK: The pivotal role of the immunoglobulin receptor of tumor cells from B cell lymphomas of mucosa associated lymphoid tissue (MALT). Adv Exp Med Biol 1994, 355:189-193
44. Qin Y, Greiner A, Trunk MJ, Schmausser B, Ott MM, Müller Hermelink HK: Somatic hypermutation in low-grade mucosa-associated lymphoid tissue-type B-cell lymphoma. Blood 1995, 86:3528-3534
45. Strand S, Hofmann WJ, Hug H, Müller M, Otto G, Strand D, Mariani SM, Stremmel W, Krammer PH, Galle PR: Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells - a mechanism of immune evasion? Nature Med 1996, 2:1361-1366
46. Gronbaek K, Straten PT, Ralfkiaer E, Ahrenkiel V, Andersen MK, Hansen NE, Zeuthen J, Hau Jensen K, Guldberg P: Somatic Fas mutations in non-Hodgkin's lymphoma: association with extranodal disease and autoimmunity. Blood 1998, 92:3018-3024
47. Plumas J, Jacob MC, Chaperot L, Molens JP, Sotto JJ, Bensa JC: Tumor B cells from non-Hodgkin's lymphoma are resistant to CD95 (Fas/Apo-1)-mediated apoptosis. Blood 1998, 91:2875-2885
48. Hauer AC, Finn TM, MacDonald TT, Spencer J, Isaacson PG: Analysis of TH1 and TH2 cytokine production in low grade B cell gastric MALT-type lymphomas stimulated in vitro with Helicobacter pylori. J Clin Pathol 1997, 50:957-959
49. King C, Davies J, Mueller R, Lee MS, Krahl T, Yeung B, O'Connor E, Sarvetnick N: TGF-β1 alters APC preference, polarizing islet antigen responses toward a Th2 phenotype. Immunity 1998, 8:601-613
50. Garcia B, Rodriguez R, Angulo I, Heath AW, Howard MC, Subiza JL: Differential effects of transforming growth factor-beta 1 on IgA vs. IgG2b production by lipopolysaccharide-stimulated lymph node B cells: a comparative study with spleen B cells. Eur J Immunol 1996, 26:2364-2370
51. Defrance T, Carayon P, Billian G, Guillemot JC, Minty A, Caput D, Ferrara P: Interleukin 13 is a B cell stimulating factor. J Exp Med 1994, 179:135-143
52. Cayeux S, Richter G, Noffz G, Dorken B, Blankenstein T: Influence of gene-modified (IL-7, IL-4, and B7) tumor cell vaccines on tumor antigen presentation. J Immunol 1997, 158:2834-2841
53. D'Elios MM, Manghetti M, De Carli M, Costa F, Baldari CT, Burroni D, Telford JL, Romagnani S, Del Prete G: T helper 1 effector cells specific for Helicobacter pylori in the gastric antrum of patients with peptic ulcer disease J Immunol 1997, 158:962-967
54. Grafton G, Goodall M, Gregory CD, Gordon J: Mechanisms of antigen receptor-dependent apoptosis of human B lymphoma cells probed with a panel of 27 monoclonal antibodies. Cell Immunol 1997, 182: 45-56